Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells

• Gal Markel ,

  * E-mail: markel@post.tau.ac.il

  Affiliations Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel, Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel, Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  ⨯
• Rachel Seidman,

  Affiliation Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Michal J. Besser,

  Affiliation Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Naama Zabari,

  Affiliation Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Rona Ortenberg,

  Affiliation Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Ronnie Shapira,

  Affiliation Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Avraham J. Treves,

  Affiliation Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Ron Loewenthal,

  Affiliation Tissue Typing Laboratory, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Arie Orenstein,

  Affiliation Center for Advanced Technologies, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Arnon Nagler,

  Affiliation Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Jacob Schachter

  Affiliation Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  ⨯